Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Profesionales de la salud / / / /
|
A Randomized Trial Comparing the Efficacy of Single Radiation Fraction with Fractionated Radiation Therapy in the Palliation of Skeletal Metastases
Presenter: P. Kirkbride Affiliation: Princess Margaret Hospital, Toronto, Canada Background: Controversy exists about whether painful bone metastases can be palliated equally well by short hypofractionated radiation therapy regimens as by... |
|
|
Advantage of protons compared to IMRT in the treatment of medulloblastoma
Presenter: W. H. St. Clair Affiliation: Massachusetts General Hospital Background: There is continued interest in finding ways to reduce the radiation related toxicity associated with the treatment of medulloblastoma. Both... |
|
|
Creating Human Cancer Cells out of Normal Cells to Better Understand the Disease Process: Biologist Robert Weinberg Describes His Lab's Successes
A human cancer cell is the product of a series of genetic mutations that transform a normal cell into a progressively abnormal cell. Currently, it is impossible for researchers to retrace the complex series of steps that were actually involved in... |
|
|
Effects of Pamidronate Use on the Palliative Radiotherapy of Bone Metastases
Presenter: M.N. Yavux Affiliation: Karadeniz University, Trabzone, Turkey Background: Between 15-70% of all cancer patients are found to have bone metastases over the course of their lifetime. These lesions are frequently painful, cause a... |
|
|
Preliminary Results from a Phase II Trial of Conformal Radiation Therapy for Localized Pediatric Brain Tumors
Presenter: TE Merchant, MD Affiliation: St. Jude Children's Research Hospital, Memphis, TN Background: Use of Conformal Radiation Therapy (CRT) for treatment of pediatric brain tumors has the potential for reducing toxicity and improving... |
|
|
Proton radiation therapy in the management of prediatric base of skull tumors
Presenter: E. B. Hug Affiliation: Loma Linda University Background: Treatment of pediatric skull base tumors is limited by the dose of radiation that can be delivered because of critical normal tissues in this region.Ê Becuase of the... |
|
|
Results From the IRS IV Randomized Trial of Hyperfractionated Radiation in Children with Rhabdomyosarcoma
Presenter: S. S. Donaldson, MD Affiliation: The Intergroup Rhabdomyosarcoma Study Background: Hyperfractionated radiation therapy (HFRT) has the theoretical potential for improving efficacy without producing more late effects of children... |
|
|
Senator Kennedy (D-MA) Tells Radiation Oncologists He Will Continue to Support Physicians' and Patients' Best Interests He Also Urges Their Involvement in Debates Over the Pain Relief Promotion Act Speaking this morning before a nearly full ballroom of ASTRO attendees, Massachusetts senator Edward M. Kennedy asserted that he will continue to be a pro-patient, pro-physician, and pro-research voice in our nation's Congress. Kennedy first... |
|
|
Submandibular Salivary Gland Transfer Prevents XRT Xerostomia
Presenter: N Jha Affiliation: Cross Cancer Institute Edmonton, AB Canada, Universsity of Alberta Background: Xerostomia is a significant problem for many patients after XRT to the head and neck. This study looks at a novel surgical... |
|
|
The Impact of Hormonal Therapy on Outcome in Moderate to High Risk Prostate Cancer Treated with Permanent Radioactive Seed Implantation
Presenter: L. N. Lee Affiliation: Mount Sinai School of Medicine, New York, NY Background: Prostate radioactive seed implantation is an effective treatment option for clinically organ- confined prostate carcinoma. Hormonal therapy (HT) ... |
Dr. Tobey discusses some of the controversy surrounding breast cancer screening with mammography. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

